不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置不用本金就能赚钱的方法>技术资料不用本金就能赚钱的方法>行业动态>公司动态>BD宣布就收购Accuri Cytometer公司达成协议

BD宣布就收购Accuri Cytometer公司达成协议

BD2011年2月14日 15:42 点击:1736

美国BD Becton, Dickinson 美国Accuri Cytometers


 

2011NIAN2YUE7RIQUANQIULINGXIANDEYILIAOJISHUGONGSIMEIGUOBD GONGSI(Becton, Dickinson and Company) (NIUYUEZHENGQUANJIAOYISUO: BDX),DUIWAIXUANBUYIJINGTONGAccuri CytometerGONGSIDACHENGQUEDINGDESHOUGOUXIEYI。 Accuri Cytometer GONGSISHIYIJIAWEIYUMEIGUOMIXIEGENZHOUAnn ArborSHIDEKAIFAHESHENGCHANKEYANXINGGERENHUALIUSHIXIBAOYIDEYIQIZHIZAOSHANG。 CIXIANGSHOUGOUXIEYIHAIJIANGTIJIAOJIANGUANBUMENPIZHUN,BINGYUJIKEZAI2011CAINIANDEDISANJIDUZHENGSHIWANCHENG。CICISHOUGOUDECHENGJIAOJINEDENGXIANGGUANCAIWUNEIRONGWEIYUGONGBU。

TONGBDYIGUANDESHOUGOUCELVEYIZHI, CICISHOUGOUJIANGHUISHIBDJINRUDAOXINXINGDEDICHENGBENGERENHUALIUSHIXIBAOYISHICHANG。YEJIANGBANGZHUBDTUOZHANQIZAIYIXIEXINXINGLINGYUDEFUGAI,TEBIESHIDUICAOZUOBIANJIEYAOQIUJIAOGAODEMOUXIELINGYU,TONGSHIYEHUIYOUZHUYUBDZAIXUDUOMUQIANLIUSHIYINGYONGHAIJIAOSHAODEKEXUELINGYUDEYEWUTUOZHAN,LIRUHUANJINGYANJIUDENG

“Accuri CytometerGONGSIMIANXIANGXINXINGYANJIUQUNTIDEGERENHUALIUSHIXIBAOYICHANPINKEYIBUCHONGHETUOKUANBDXIANYOUDECHANPINXIAN。”BDZONGCAIHEGONGSISHOUXIYUNYINGGUANVincent A. ForlenzaSHUO:“WOMENXIANGXIN,YIDANSHOUGOUWANCHENG,JIANGHUISHIBDDUIYILIAOJIKEXUELINGYUDEFAZHANZUOCHUGENGDADEGONGXIAN,ZHEIYEFUHEBDGONGSI“BANGZHURENLEIJIANKANGSHENGHUO”DEGONGSIZONGZHI。

“RANGLIUSHIXIBAOJISHUZAIGENGGUANGDADEKEYANJILINCHUANGYONGHUQUNTIZHONGDEDAOGENGGUANGFANDEYINGYONGSHIXIBAOFENXISHICHANGZENGZHANGCELVEDEYIBUFEN”BD SHENGWUKEXUEZONGCAIWilliam RhodesSHUO。“Accuri LIUSHIXIBAOYIDEXIAOXINGHUAJISHEN,CAOZUOBIANJIEXINGHEJINGJIDEGOUZHIJIAGE,JIANGHUICUSHILIUSHIXIBAOJISHUZAIBDMUQIANHAIMEIYOUFUWUDAODEYANJIUZHEZHONGDEDAOGUANGFANYINGYONGHEPUJI”。

关于BD

BD是世界上最大的生产和销售医疗设备、医疗系统和试剂的医疗技术公司之一。致力于提高全世界人类的健康水平。BD专注于改进药物治疗,提高传染性疾病诊断的质量和速度,推进新型药物和疫苗的研究与发现。BD公司具有强大的研发能力和世界上最棘手的多种疾病进行斗争。公司于1897年在纽约成立,总部位于美国新泽西州的富兰克林湖,业务遍及全球。公司的业务可分为BD医疗、BD诊断、BD生物科学三大类,生产销售包括医用耗材、实验室仪器、抗体、试剂、诊断等产品。公司的服务对象包括医疗机构,生命科学研究所,临床实验室,工业单位和普通大众。


Would Broaden Flow Cytometry Offerings to Researchers

Contact: Zachary A. Nagle
Investor Relations
(201) 847-5453
Email: Zachary_Nagle@bd.com

Colleen T.  White
Corporate Communications
(201) 847-5369
Email: colleen_white@bd.com

Franklin Lakes, NJ (February 7, 2011) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it signed a definitive agreement to acquire Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers.  The acquisition is subject to regulatory approvals and is expected to close during the third quarter of fiscal year 2011. The financial terms of the agreement were not disclosed. 

不用本金就能赚钱的方法Consistent with BD’s acquisition strategy, the acquisition would expand BD’s presence into the emerging affordable personal flow cytometer space. It would also help expand the use of flow technology by researchers in developing regions where ease of use is critical, as well as by researchers in scientific disciplines that have not traditionally used flow cytometry, such as environmental studies.

不用本金就能赚钱的方法“Accuri Cytometers’ offering of flow cytometers for a new audience of researchers will complement and broaden BD’s current offerings for life scientists,” said Vincent A. Forlenza, BD President and Chief Operating Officer. “We believe that, once completed, this acquisition will enable BD to further contribute to medical and scientific advances, in line with our corporate purpose of helping all people live healthy lives.”

不用本金就能赚钱的方法“Making flow cytometry more accessible to a wider audience of scientists and clinicians is one aspect of our Cell Analysis growth strategy,” said William Rhodes, President, BD Biosciences. “With its small footprint, ease of use and affordable price, the Accuri flow cytometer enables the adoption of flow cytometry by a broad range of researchers whom BD does not currently serve.”

BD senior management will address this announcement during the Company’s fiscal first quarter earnings call on February 8, 2011, which will be broadcast live on BD's website, www.bd.com/investors, at 10:00 a.m. (ET).
不用本金就能赚钱的方法  

About BD

不用本金就能赚钱的方法BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit .

(来源: BD )


全年征稿 / 资讯合作

联系邮箱:kefu@strauss-usa.com

BANQUANYUMIANZESHENGMING

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://strauss-usa.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图